Unscheduled Akt-Triggered Activation of Cyclin-Dependent Kinase 2 as a Key Effector Mechanism of Apoptin's Anticancer Toxicity

REFERENCES

• Ahn, J. Y., X. Liu, Z. Liu, L. Pereira, D. Cheng, J. Peng, P. A. Wade, A. W. Hamburger, and K. Ye. 2006. Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase. EMBO J. 25:2083–2095.
   PubMed Web of Science ®Google Scholar
• Aki, T., K. Yamaguchi, T. Fujimiya, and Y. Mizukami. 2003. Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocyte-derived cell line H9c2. Oncogene 22:8529–8535.
   PubMedGoogle Scholar
• Backendorf, C., A. E. Visser, A. G. de Boer, R. Zimmerman, M. Visser, P. Voskamp, Y. H. Zhang, and M. H. Noteborn. 2008. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu. Rev. Pharmacol. Toxicol. 48:143–169.
   PubMedGoogle Scholar
• Barkett, M., and T. D. Gilmore 1999. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18:6910–6924.
   PubMed Web of Science ®Google Scholar
• Bashir, T., N. V. Dorrello, V. Amador, D. Guardavaccaro, and M. Pagano. 2004. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 428:190–193.
   PubMed Web of Science ®Google Scholar
• Berthet, C., E. Aleem, V. Coppola, L. Tessarollo, and P. Kaldis. 2003. Cdk2 knockout mice are viable. Curr. Biol. 13:1775–1785.
   PubMed Web of Science ®Google Scholar
• Booy, E. P., D. Johar, S. Maddika, H. Pirzada, M. M. Sahib, I. Gehrke, S. D. Loewen, S. D. Louis, K. Kadkhoda, M. Mowat, and M. Los. 2006. Monoclonal and bispecific antibodies as novel therapeutics. Arch. Immunol. Ther. Exp. 54:1–17.
   PubMedGoogle Scholar
• Burek, M., S. Maddika, C. J. Burek, P. T. Daniel, K. Schulze-Osthoff, and M. Los. 2006. Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent. Oncogene 25:2213–2222.
   PubMed Web of Science ®Google Scholar
• Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193–199.
   PubMed Web of Science ®Google Scholar
• Chae, H. D., B. M. Kim, U. J. Yun, and D. Y. Shin. 2008. Deregulation of Cdk2 causes Bim-mediated apoptosis in p53-deficient tumors following actin damage. Oncogene 27:4115–4121.
   PubMedGoogle Scholar
• Cheng, J. Q., C. W. Lindsley, G. Z. Cheng, H. Yang, and S. V. Nicosia. 2005. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 24:7482–7492.
   PubMed Web of Science ®Google Scholar
• Coffer, P. J., J. Jin, and J. R. Woodgett. 1998. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335:1–13.
   PubMed Web of Science ®Google Scholar
• Danen-Van Oorschot, A. A., D. F. Fischer, J. M. Grimbergen, B. Klein, S. Zhuang, J. H. Falkenburg, C. Backendorf, P. H. Quax, A. J. Van der Eb, and M. H. Noteborn. 1997. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc. Natl. Acad. Sci. USA 94:5843–5847.
   PubMed Web of Science ®Google Scholar
• Danen-van Oorschot, A. A., A. J. van der Eb, and M. H. Noteborn. 2000. The chicken anemia virus-derived protein apoptin requires activation of caspases for induction of apoptosis in human tumor cells. J. Virol. 74:7072–7078.
   PubMedGoogle Scholar
• Downward, J. 2004. PI 3-kinase, Akt and cell survival. Semin. Cell. Dev. Biol. 15:177–182.
   PubMed Web of Science ®Google Scholar
• Du, K., and P. N. Tsichlis. 2005. Regulation of the Akt kinase by interacting proteins. Oncogene 24:7401–7409.
   PubMedGoogle Scholar
• Freemantle, S. J., M. J. Spinella, and E. Dmitrovsky. 2003. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22:7305–7315.
   PubMed Web of Science ®Google Scholar
• Fujio, Y., K. Guo, T. Mano, Y. Mitsuuchi, J. R. Testa, and K. Walsh. 1999. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol. Cell. Biol. 19:5073–5082.
   PubMedGoogle Scholar
• Fulda, S., and K. M. Debatin. 2004. Apoptosis signaling in tumor therapy. Ann. N. Y. Acad. Sci. 1028:150–156.
   PubMedGoogle Scholar
• Ganoth, D., G. Bornstein, T. K. Ko, B. Larsen, M. Tyers, M. Pagano, and A. Hershko. 2001. The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27. Nat. Cell Biol. 3:321–324.
   PubMed Web of Science ®Google Scholar
• Gil-Gomez, G., A. Berns, and H. J. Brady. 1998. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J. 17:7209–7218.
   PubMed Web of Science ®Google Scholar
• Golsteyn, R. M. 2005. Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle. Cancer Lett. 217:129–138.
   PubMed Web of Science ®Google Scholar
• Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:3995–4005.
   PubMed Web of Science ®Google Scholar
• Guelen, L., H. Paterson, J. Gaken, M. Meyers, F. Farzaneh, and M. Tavassoli. 2004. TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene 23:1153–1165.
   PubMed Web of Science ®Google Scholar
• Guseva, N. V., A. F. Taghiyev, O. W. Rokhlin, and M. B. Cohen. 2002. Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3. Prostate 51:231–240.
   PubMedGoogle Scholar
• Hakem, A., T. Sasaki, I. Kozieradzki, and J. M. Penninger. 1999. The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis. J. Exp. Med. 189:957–968.
   PubMed Web of Science ®Google Scholar
• Hoang, A. T., K. J. Cohen, J. F. Barrett, D. A. Bergstrom, and C. V. Dang. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA 91:6875–6879.
   PubMedGoogle Scholar
• Jänicke, R. U., D. Sohn, F. Essmann, and K. Schulze-Osthoff. 2007. The multiple battles fought by anti-apoptotic p21. Cell Cycle 6:407–413.
   PubMed Web of Science ®Google Scholar
• Janssen, K., T. G. Hofmann, D. A. Jans, R. T. Hay, K. Schulze-Osthoff, and U. Fischer. 2007. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies. Oncogene 26:1557–1566.
   PubMed Web of Science ®Google Scholar
• Klanrit, P., M. B. Flinterman, E. W. Odell, G. Melino, R. Killick, J. S. Norris, and M. Tavassoli. 2008. Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin. Cell Cycle 7:205–215.
   PubMed Web of Science ®Google Scholar
• Kunstle, G., J. Laine, G. Pierron, S. Kagami Si, H. Nakajima, F. Hoh, C. Roumestand, M. H. Stern, and M. Noguchi. 2002. Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1. Mol. Cell. Biol. 22:1513–1525.
   PubMed Web of Science ®Google Scholar
• Levkau, B., H. Koyama, E. W. Raines, B. E. Clurman, B. Herren, K. Orth, J. M. Roberts, and R. Ross. 1998. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell 1:553–563.
   PubMed Web of Science ®Google Scholar
• Liang, J., and J. M. Slingerland. 2003. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2:339–345.
   PubMed Web of Science ®Google Scholar
• Liang, J., J. Zubovitz, T. Petrocelli, R. Kotchetkov, M. K. Connor, K. Han, J. H. Lee, S. Ciarallo, C. Catzavelos, R. Beniston, E. Franssen, and J. M. Slingerland. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8:1153–1160.
   PubMed Web of Science ®Google Scholar
• Lin, B., S. K. Kolluri, F. Lin, W. Liu, Y. H. Han, X. Cao, M. I. Dawson, J. C. Reed, and X. K. Zhang. 2004. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116:527–540.
   PubMed Web of Science ®Google Scholar
• Los, M., C. Stroh, R. U. Janicke, I. H. Engels, and K. Schulze-Osthoff. 2001. Caspases: more than just killers? Trends Immunol. 22:31–34.
   PubMedGoogle Scholar
• Lu, B., L. Wang, C. Stehlik, D. Medan, C. Huang, S. Hu, F. Chen, X. Shi, and Y. Rojanasakul. 2006. Phosphatidylinositol 3-kinase/Akt positively regulates Fas (CD95)-mediated apoptosis in epidermal Cl41 cells. J. Immunol. 176:6785–6793.
   PubMed Web of Science ®Google Scholar
• Luciano, F., M. Krajewska, P. Ortiz-Rubio, S. Krajewski, D. Zhai, B. Faustin, J. M. Bruey, B. Bailly-Maitre, A. Lichtenstein, S. K. Kolluri, A. C. Satterthwait, X. K. Zhang, and J. C. Reed. 2007. Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma. Blood 109:3849–3855.
   PubMed Web of Science ®Google Scholar
• Maddika, S., S. R. Ande, E. Wiechec, L. L. Hansen, S. Wesselborg, and M. Los. 2008. Akt mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis. J. Cell Sci. 121:979–988.
   PubMed Web of Science ®Google Scholar
• Maddika, S., G. H. Bay, T. J. Kroczak, S. R. Ande, S. Maddika, E. Wiechec, S. B. Gibson, and M. Los. 2007. Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death. Cell. Prolif. 40:835–848.
   PubMedGoogle Scholar
• Maddika, S., E. P. Booy, D. Johar, S. B. Gibson, S. Ghavami, and M. Los. 2005. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J. Cell Sci. 118:4485–4493.
   PubMed Web of Science ®Google Scholar
• Maddika, S., E. Wiechec, S. R. Ande, I. K. Poon, U. Fischer, S. Wesselborg, D. A. Jans, K. Schulze-Osthoff, and M. Los. 2008. Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin. Oncogene 27:3060–3065.
   PubMedGoogle Scholar
• Manning, B. D., and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell 129:1261–1274.
   PubMed Web of Science ®Google Scholar
• Medema, R. H., G. J. Kops, J. L. Bos, and B. M. Burgering. 2000. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782–787.
   PubMed Web of Science ®Google Scholar
• Nahta, R., D. Yu, M. C. Hung, G. N. Hortobagyi, and F. J. Esteva. 2006. Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat. Clin. Pract. Oncol. 3:269–280.
   PubMedGoogle Scholar
• Nakayama, K., H. Nagahama, Y. A. Minamishima, M. Matsumoto, I. Nakamichi, K. Kitagawa, M. Shirane, R. Tsunematsu, T. Tsukiyama, N. Ishida, M. Kitagawa, K. Nakayama, and S. Hatakeyama. 2000. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19:2069–2081.
   PubMed Web of Science ®Google Scholar
• Nimbalkar, D., M. K. Henry, and F. W. Quelle. 2003. Cytokine activation of phosphoinositide 3-kinase sensitizes hematopoietic cells to cisplatin-induced death. Cancer Res. 63:1034–1039.
   PubMedGoogle Scholar
• Oro, C., and D. A. Jans. 2004. The tumour specific pro-apoptotic factor apoptin (Vp3) from chicken anaemia virus. Curr. Drug Targets 5:179–190.
   PubMedGoogle Scholar
• Pekarsky, Y., A. Koval, C. Hallas, R. Bichi, M. Tresini, S. Malstrom, G. Russo, P. Tsichlis, and C. M. Croce. 2000. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc. Natl. Acad. Sci. USA 97:3028–3033.
   PubMed Web of Science ®Google Scholar
• Piccaluga, P. P., M. Rondoni, S. Paolini, G. Rosti, G. Martinelli, and M. Baccarani. 2007. Imatinib mesylate in the treatment of hematologic malignancies. Expert Opin. Biol. Ther. 7:1597–1611.
   PubMed Web of Science ®Google Scholar
• Pietersen, A. M., M. M. van der Eb, H. J. Rademaker, D. J. van den Wollenberg, M. J. Rabelink, P. J. Kuppen, J. H. van Dierendonck, H. van Ormondt, D. Masman, C. J. van de Velde, A. J. van der Eb, R. C. Hoeben, and M. H. Noteborn. 1999. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene. Gene Ther. 6:882–892.
   PubMed Web of Science ®Google Scholar
• Poon, I. K., C. Oro, M. M. Dias, J. Zhang, and D. A. Jans. 2005. Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res. 65:7059–7064.
   PubMed Web of Science ®Google Scholar
• Poon, R. Y., J. Lew, and T. Hunter. 1997. Identification of functional domains in the neuronal Cdk5 activator protein. J. Biol. Chem. 272:5703–5708.
   PubMedGoogle Scholar
• Riccardi, C., and I. Nicoletti. 2006. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc. 1:1458–1461.
   PubMed Web of Science ®Google Scholar
• Rohn, J. L., Y. H. Zhang, R. I. Aalbers, N. Otto, J. Den Hertog, N. V. Henriquez, C. J. Van De Velde, P. J. Kuppen, D. Mumberg, P. Donner, and M. J. Noteborn. 2002. A tumor-specific kinase activity regulates the viral death protein apoptin. J. Biol. Chem. 277:50820–50827.
   PubMed Web of Science ®Google Scholar
• Sekimoto, T., M. Fukumoto, and Y. Yoneda. 2004. 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1). EMBO J. 23:1934–1942.
   PubMedGoogle Scholar
• Shack, S., X. T. Wang, G. C. Kokkonen, M. Gorospe, D. L. Longo, and N. J. Holbrook. 2003. Caveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity. Mol. Cell. Biol. 23:2407–2414.
   PubMedGoogle Scholar
• Spruck, C., H. Strohmaier, M. Watson, A. P. Smith, A. Ryan, T. W. Krek, and S. I. Reed. 2001. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol. Cell 7:639–650.
   PubMed Web of Science ®Google Scholar
• Tavassoli, M., L. Guelen, B. A. Luxon, and J. Gaken. 2005. Apoptin: specific killer of tumor cells? Apoptosis 10:717–724.
   PubMed Web of Science ®Google Scholar
• Teodoro, J. G., D. W. Heilman, A. E. Parker, and M. R. Green. 2004. The viral protein apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev. 18:1952–1957.
   PubMed Web of Science ®Google Scholar
• Trotman, L. C., A. Alimonti, P. P. Scaglioni, J. A. Koutcher, C. Cordon-Cardo, and P. P. Pandolfi. 2006. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441:523–527.
   PubMedGoogle Scholar
• Tsvetkov, L. M., K. H. Yeh, S. J. Lee, H. Sun, and H. Zhang. 1999. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661–664.
   PubMed Web of Science ®Google Scholar
• Van Gorp, A. G., K. M. Pomeranz, K. U. Birkenkamp, R. C. Hui, E. W. Lam, and P. J. Coffer. 2006. Chronic protein kinase B (PKB/c-akt) activation leads to apoptosis induced by oxidative stress-mediated Foxo3a transcriptional up-regulation. Cancer Res. 66:10760–10769.
   PubMedGoogle Scholar
• Vivanco, I., and C. L. Sawyers. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2:489–501.
   PubMed Web of Science ®Google Scholar
• Wada, T., and J. M. Penninger. 2004. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838–2849.
   PubMed Web of Science ®Google Scholar
• Wei, W., N. G. Ayad, Y. Wan, G. J. Zhang, M. W. Kirschner, and W. G. Kaelin, Jr. 2004. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428:194–198.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R., L. Clay-Farrace, W. van Zon, M. Yekezare, L. Koop, J. Ogink, R. Medema, and J. Pines. 2008. Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A. Mol. Cell 30:290–302.
   PubMed Web of Science ®Google Scholar
• Yam, C. H., T. K. Fung, and R. Y. Poon. 2002. Cyclin A in cell cycle control and cancer. Cell. Mol. Life Sci. 59:1317–1326.
   PubMed Web of Science ®Google Scholar